CIK 0001622229 · Large accelerated filer
Cogent Biosciences, Inc.
Sign in to watch- Ticker
- COGT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465308248
- Phone
- 617-945-5576
- Business address
- 180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
- Former names
- Unum Therapeutics Inc., Unum Therapeutics, Inc.
- PRER14A Other PRER14A
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Acquisition or sale completed · Regulation FD disclosure
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- PRER14A Other PRER14A
- SC 13G/A Stake Amended Statement of Ownership
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- UPLOAD Other SEC-generated Letter
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement
- PRE 14A Proxy Proxy Statement (Preliminary)
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
Page 21 of 31 · 616 filings